NephroGenex, Inc. Deferred Offering Costs
NephroGenex, Inc. had Deferred Offering Costs of $392.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2015-08-12
- 2015-06-30: Deferred Offering Costs $392.00K.
- 2014-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2015-06-30 | $392.00K 10-Q · filed 2015-08-12 |
| 2014-12-31 | $0.00 10-Q · filed 2015-08-12 |